Stonepine Capital Management, LLC - STRONGBRIDGE BIOPHARMA PLC ownership

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$9,159,000
-6.7%
4,489,687
+35.8%
4.17%
-18.8%
Q2 2021$9,818,000
+698.2%
3,305,617
+641.7%
5.13%
+673.2%
Q1 2021$1,230,000
-62.5%
445,701
-67.0%
0.66%
-73.6%
Q4 2020$3,281,000
-18.8%
1,350,000
-29.9%
2.51%
-40.3%
Q3 2020$4,042,000
+347.6%
1,924,956
+345.7%
4.20%
+568.5%
Q4 2019$903,000
+77.8%
431,853
+166.2%
0.63%
+79.7%
Q2 2019$508,000
-45.5%
162,244
-13.3%
0.35%
-34.7%
Q1 2019$932,000
-62.7%
187,074
-45.7%
0.54%
-64.2%
Q4 2017$2,496,000344,2821.50%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 978,907$6,865,0003.28%
RA Capital Management 2,690,702$20,449,0002.02%
NEA Management Company, LLC 2,141,308$16,274,0001.04%
Broadfin Capital, LLC 1,656,705$10,911,0000.67%
Tredje AP-fonden 909,581$6,913,0000.44%
Granite Point Capital Management, L.P. 388,945$2,679,0000.40%
Ghost Tree Capital, LLC 72,726$553,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 181,818$1,382,0000.20%
Tower Research Capital LLC (TRC) 1,094$8,0000.00%
ACADIAN ASSET MANAGEMENT LLC 1,373$10,0000.00%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders